Health Care › BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
KYMR Stock Price Correlated With Kymera Therapeutics Financials
External Links ⌄
Income Statement
Cash Flow
Balance Sheet
KYMR Income Statement
Enable JavaScript and reload
Revenue, Net:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
KYMR Cash Flow
Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:
KYMR Balance Sheet
Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:
Free historical financial statements for Kymera Therapeutics Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 19 quarters since 2020. Compare with KYMR stock chart to see long term trends.
Data imported from Kymera Therapeutics Inc. SEC filings. Check original filings before making any investment decision.